Implementing evidence-based treatment of manic and mixed episodes

Journal of Clinical Psychiatry

Volumn 67, Issue SUPPL. 11, 2006, Pages 12-17

  Sachs, Gary S ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; DIURETIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PERAZINE; QUETIAPINE; RISPERIDONE; TOPIRAMATE; TRANQUILIZER; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

ALGORITHM; BIPOLAR DISORDER; ELECTROCONVULSIVE THERAPY; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; MANIA; MENTAL HEALTH CARE; MIXED MANIA AND DEPRESSION; OVARY POLYCYSTIC DISEASE; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

ACUTE DISEASE; ANTIMANIC AGENTS; BIPOLAR DISORDER; CRITICAL PATHWAYS; DECISION TREES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FOLLOW-UP STUDIES; HUMANS; PATIENT CARE MANAGEMENT; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 33748978774     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Sachs GS, Thase ME, Otto MW, et al. Rationale, design, and methods of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry 2003;53:1028-1042
2. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex versus lithium and placebo in the treatment of mania. JAMA 1994;271:918-924. Correction 1994;271:1830
3. Keck PE Jr, Marcus R, Tourkodimitris S, et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 2003;160:1651-1658
4. Weisler RH, Kalali AH, Ketter TA, for the SPD417 Study Group. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004;65:478-484
5. Weisler RH, Keck PE Jr, Swann AC, et al, for the SPD417 Study Group. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2005;66:323-330
6. Vasudev K, Goswami U, Kohli K. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. Psychopharmacology (Berl) 2000;150:15-23
7. Tohen M, Sanger TM, McElroy SL, et al. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999;156:702-709
8. Tohen M, Jacobs TG, Grundy SL, et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Olanzapine HGGW Study Group. Arch Gen Psychiatry 2000;57:841-849. Correction 2002;59:91
9. Bowden CL, Grunze H, Mullen J, et al. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 2005;66:111-121
10. Vieta E, Mullen J, Brecher M, et al. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Curr Res Med Opin 2005;21:923-934
11. McIntyre RS, Brecher M, Paulsson B, et al. Quetiapine or haloperidol as monotherapy for bipolar mania: a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur Neuropsychopharmacol 2005;15:573-585
12. Smulevich AB, Khanna S, Eerdekens M, et al. Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. Eur Neuropsychopharmacol 2005;15:75-84
13. Gopal S, Steffens DC, Kramer ML, et al. Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy. J Clin Psychiatry 2005;66:1016-1020
14. Hirschfeld RMA, Keck PE Jr, Kramer M, et al. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am J Psychiatry 2004;161:1057-1065
15. Khanna S, Hirschfeld RMA, Karcher K, et al. Risperidone monotherapy in acute bipolar mania. In: New Research Abstracts of the 156th Annual Meeting of the American Psychiatric Association; May 17-22, 2003; San Francisco, Calif. Abstract NR424:159
16. Khanna S, Vieta E, Lyons B, et al. Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry 2005;187:229-234
17. Keck PE Jr, Versiani M, Potkin S, et al. Ziprasidone in the treatment of acute bipolar mania: a three-week, double-blind, randomized trial. Am J Psychiatry 2003;160:741-748
18. Anand A, Oren DA, Berman A, et al. Lamotrigine treatment of lithium failure outpatient mania [abstract]. Bipolar Disord 1999;1:23
19. Pande AC, Crockatt JG, Janney CA, et al. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Bipolar Disord 2000;2(3 pt 2):249-255
20. Kushner SF, Khan A, Lane R, et al. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials. Bipolar Disord 2006;8:15-27
21. Calabrese JR, Keck PE Jr, Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005;162:1351-1360
22. Muller-Oerlinghausen B, Retzow A, Henn FA, et al. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. J Clin Psychopharmacol 2000;20:195-203
23. Baker RW, Brown E, Akiskal HS, et al. Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. Br J Psychiatry 2004;185:472-478
24. Zarate CA Jr, Narendran R, Tohen M, et al. Clinical predictors of acute response with olanzapine in psychotic mood disorders. J Clin Psychiatry 1998;59:24-28
25. Sachs G, Ghaemi SN. Safety and efficacy of risperidone versus placebo in combination with lithium or valproate in the treatment of the manic phase of bipolar disorder. Int J Neuropsychopharmacol 2000;3(suppl 1):S143
26. Yatham LN, Grossman F, Augustynes I, et al. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. Br J Psychiatry 2003;182:141-147
27. Sachs GS, Grossman F, Ghaemi SN, et al. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of safety and efficacy. Am J Psychiatry 2002;159:1146-1154
28. Yatham LN, Paulsson B, Mullen J, et al. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol 2004;24:599-606
29. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, et al. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care 2004;27:596-601
30. Tohen M, Chengappa KN, Suppes T, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002;59:62-69
31. Jafari M, Jiang P, Casey DE. Adjunctive divalproex sodium lowers cholesterol elevation with olanzapine. In: New Research Abstracts of the 157th Annual Meeting of the American Psychiatric Association; May 5, 2004; New York, NY. Abstract NR634:238
32. Joffe H, Cohen LS, Suppes T, et al. Polycystic ovarian syndrome is associated with valproate use in bipolar women. In: New Research Abstracts of the 157th Annual Meeting of the American Psychiatric Association; May 3, 2004; New York, NY. Abstract NR264:98
33. Isojarvi JI, Laatikainen TJ, Pakarinen AJ, et al. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993;329:1383-1388
34. Silverstone PH, Silverstone T. A review of acute treatments for bipolar depression. Int Clin Psychopharmacol 2004;19:113-124
35. Sachs GS. Treatment of acute depression in bipolar disorder. In: Ketter TA, ed. Advances in Treatment of Bipolar Disorder. Washington, DC: American Psychiatric Publishing; 2005:57-109